Cg Oncology Common Stock Statistic Functions Beta
| CGON Stock | 53.81 2.04 3.65% |
| Symbol |
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on CG Oncology Common correlated with the market. If Beta is less than 0 CG Oncology generally moves in the opposite direction as compared to the market. If CG Oncology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CG Oncology Common is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CG Oncology is generally in the same direction as the market. If Beta > 1 CG Oncology moves generally in the same direction as, but more than the movement of the benchmark.
CG Oncology Technical Analysis Modules
Most technical analysis of CG Oncology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for CGON from various momentum indicators to cycle indicators. When you analyze CGON charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CG Oncology Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CG Oncology Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of CG Oncology Common based on widely used predictive technical indicators. In general, we focus on analyzing CGON Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CG Oncology's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of CG Oncology's intrinsic value. In addition to deriving basic predictive indicators for CG Oncology, we also check how macroeconomic factors affect CG Oncology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 164.61 | 250.28 | 225.25 | 198.8 | PTB Ratio | 13.4 | 2.44 | 2.81 | 2.67 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CG Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CG Oncology's short interest history, or implied volatility extrapolated from CG Oncology options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Dividend Beast Invested over 30 shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Investor Favorites Invested over 20 shares | |
 | Video Games Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | ESG Investing Invested few shares | |
 | Manufacturing Invested over 60 shares | |
 | Momentum Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Macroaxis Index Invested over 40 shares | |
 | Cash Cows Invested few shares | |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CG Oncology Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CG Oncology. If investors know CGON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CG Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.05) | Revenue Per Share | Quarterly Revenue Growth 37.744 | Return On Assets | Return On Equity |
The market value of CG Oncology Common is measured differently than its book value, which is the value of CGON that is recorded on the company's balance sheet. Investors also form their own opinion of CG Oncology's value that differs from its market value or its book value, called intrinsic value, which is CG Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CG Oncology's market value can be influenced by many factors that don't directly affect CG Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CG Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if CG Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CG Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.